• Cell Therapy
  • Gene Therapy
  • Exosomes
  • Tissue Engineering
  • Bioprocessing

Your Path to Therapeutic Commercialization

At RoosterBio, we are experts in radically simplifying the use of adult human mesenchymal stem/stromal cells (hMSCs) to propel the commercialization of therapeutic technologies. By enabling living cells to become more affordable at the lowest cost per million cells with industry leading quality, we make MSCs easier to access and much simpler to incorporate into product development efforts, leading to rapid acceleration in products coming to market that incorporate these technologies.

Research & Optimization

High quality raw materials with built-in processes and protocols make it easy to establish MSCs in new programs.

Product & Process Development

Our complete hMSC systems offer robust and affordable solutions that allow you to focus on your final development goals.

Tech Transfer & Manufacturing

Seamlessly translate into the clinic with off-the-shelf cGMP products and processes that scale alongside you.

Our Scalable Bioprocessing Solutions

No matter your scale, our hMSC and exosome systems with built-in processes significantly shorten development timelines and reduce costs on your journey to clinic and market.

Development Award

Applications Now Open!

2024 Development Award

Now Accepting Submissions to Support Novel MSC & Exosome Projects with Awards Totaling Up to $100,000

Submit Your Application

Why RoosterBio?

Global Presence

Supports over 200 government, academia, institution, and industry partners from more than 25 countries across 6 continents.

Regulatory Expertise

Our cGMP media and cells, supported by Type II FDA Master Files, are being used as ancillary and raw starting materials for multiple ongoing and planned registered clinical trials.

Thought Leadership

Over 350 peer reviewed journal articles have cited RoosterBio cells and media since 2015.

What Customers Say

We’ve been very pleased with the performance of Rooster cells and media that we’ve purchased - they’ve performed very well and consistently with specifications. We’ve been particularly impressed with the quality of the Rooster team - both their expertise and commitment to customer service. They’ve gone the extra mile in helping us get up to speed with their products and have been a pleasure to work with.

BioTech CEO

RoosterBio products have facilitated my research involving bone marrow-derived MSCs by providing high-quality products that have been tested for purity and performance. The robust MSC characterization practices followed by RoosterBio is important for my lab’s research, and thus RoosterBio MSCs are our first choice in commercial cell procurement.

Rebekah Samsonraj
Assistant Professor, University of Arkansas

Our CMC consultants recommended RoosterBio's platform as the industry's "gold standard" in MSC manufacturing. We found the RoosterKit for growing human bone marrow-derived MSCs straightforward and easy to use, with all the guesswork taken out of the cell culture process.

BioTech Company

One of the greatest advantages of using RoosterBio MSCs is that it enables us to directly use hundreds of millions of cells for the fabrication of densely-packed spheroids or cell-laden hydrogels at physiologically-relevant cell densities. This is believed to have a huge impact on the fabrication of scalable tissues with a great potential in replacing clinically relevant tissue or organ loss.

Ibrahim Ozbolat
Professor, Penn State University